Singular case of osteolytic lesions revealing transformation of myeloproliferative syndrome to acute leukemia - 02/03/19
pages | 3 |
Iconographies | 2 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | Hematological malignancies can be responsible for bone lesions, which are usually characterized by osteolysis. |
• | Osteosclerosis is the most common type of bone lesion in myeloproliferative syndromes. |
• | The development of an osteolytic lesion in a patient with a myeloproliferative syndrome should prompt investigations for acute transformation of the hematological disease. |
Abstract |
Hematological malignancies can cause bone lesions, of which the most common are the punched-out foci of osteolysis seen in multiple myeloma. However, osteosclerotic lesions are more common in myeloproliferative disorders. We report the unusual case of a patient with myeloproliferative syndrome in whom the development of osteolytic lesions revealed transformation to acute leukemia. In 2007, this 82-year-old man with essential thrombocythemia since 1994 developed primary polycythemia with the JAK2 mutation V617F. In July 2017, he was evaluated for an osteolytic lesion in the right humerus with incipient fracturing. Bone marrow smear results provided only limited information, due to the myelofibrosis, showing 7% of blast cells with no plasmacytosis. No solid malignancies were identified by imaging studies. Examination of a right humeral biopsy specimen taken during internal fixation showed myeloproliferative syndrome with osteosclerosis and grade-3 myelofibrosis, as well as a malignant proliferation of large cells carrying the leukocyte cluster of differentiation antigens CD45, CD 43, CD4, and CD34. The diagnosis was transformation of the myeloproliferative syndrome to acute myeloid leukemia. The development of an osteolytic lesion during the course of myeloproliferative syndrome is an exceedingly rare event that should suggest acute leukemic transformation.
Le texte complet de cet article est disponible en PDF.Keywords : Hematological malignancy, Primary polycythemia, Osteolysis, Myelofibrosis, Acute leukemia
Plan
Vol 86 - N° 2
P. 251-253 - mars 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?